Patents by Inventor Terry Reisine

Terry Reisine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7235366
    Abstract: The invention relates generally to compositions of and methods for obtaining opioid receptor polypeptides. The invention relates as well to polynucleotides encoding opioid receptor polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant opioid receptor polypeptides. By way of example, the invention discloses the cloning and functional expression of at least three different opioid receptor polypeptides. The invention includes as well, methods for using the isolated, recombinant receptor polypeptides in assays designed to select and improve substances capable of interacting with opioid receptor polypeptides for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: June 26, 2007
    Assignee: ARCH Development Corporation
    Inventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda
  • Publication number: 20030211537
    Abstract: The invention relates generally to compositions of and methods for obtaining opioid receptor polypeptides. The invention relates as well to polynucleotides encoding opioid receptor polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant opioid receptor polypeptides. By way of example, the invention discloses the cloning and functional expression of at least three different opioid receptor polypeptides. The invention includes as well, methods for using the isolated, recombinant receptor polypeptides in assays designed to select and improve substances capable of interacting with opioid receptor polypeptides for use in diagnostic, drug design and therapeutic applications.
    Type: Application
    Filed: October 21, 2002
    Publication date: November 13, 2003
    Applicant: Arch Development Corporation
    Inventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda
  • Patent number: 6319686
    Abstract: The invention relates generally to compositions of and methods for obtaining opioid receptor polypeptides. The invention relates as well to polynucleotides encoding opioid receptor polypeptides. More specifically, the invention relates to polynucleotides encoding kappa opioid receptor polypeptides, the recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant opioid receptor polypeptides. By way of example, the invention discloses the cloning and functional expression of at least three different opioid receptor polypeptides. The invention includes as well, methods for using the isolated, recombinant receptor polypeptides in assays designed to select and improve substances capable of interacting with opioid receptor polypeptides for use in diagnostic, drug design and therapeutic applications.
    Type: Grant
    Filed: August 19, 1994
    Date of Patent: November 20, 2001
    Assignee: Arch Development Corporation
    Inventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda
  • Patent number: 6096513
    Abstract: The invention relates generally to compositions of and methods for using polynucleotides encoding kappa opioid receptors. In addition to such polynucleotides themselves, the invention relates to expression vectors comprising polynucleotides encoding kappa opioid receptors, recombinant host cells comprising such polynucleotides, and processes for preparing kappa opioid receptor polypeptides.
    Type: Grant
    Filed: November 5, 1993
    Date of Patent: August 1, 2000
    Assignee: Arch Development Corporation
    Inventors: Graeme I. Bell, Terry Reisine, Kazuki Yasuda